Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)

9.065 -0.065 (-0.71%)
Streaming Delayed Price Updated: 1:04 PM EDT, Apr 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Telix Pharmaceuticals Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
From Pomerantz LLP
Via GlobeNewswire
News headline image
TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Telix H1 2025 Results: Investor Webcast Notification
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Telix Pharmaceuticals Limited (TLX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Telix Pharmaceuticals Limited (TLX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Telix Pharmaceuticals Limited (TLX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Texas Instruments, SAP, Enphase Energy And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket ↗
Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results. 
Via Benzinga
News headline image
Telix Reports $204M Revenue, Up 63% YOY
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Gozellix Receives Permanent HCPCS Code
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains ↗
Via Benzinga
News headline image
This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday ↗
 
Via Benzinga
News headline image
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix Precision Medicine Announces AlFluor Radiochemistry Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
 
Via Benzinga
News headline image
Telix Investor Day in New York City on June 11, 2025: Presenting KOLs
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix to Host Investor Day in New York City on June 11, 2025
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent 
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Telix Reports US$186M Q1 Revenue, Up 62% YOY
From Telix Pharmaceuticals Limited
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.